Contact us in Quebec


Here in Quebec, we are home to a strong community of volunteers, donors and sponsors, as well as an innovative team of researchers and health professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved! Every volunteer, donor, researcher and sponsor helps us to improve the lives of those affected by Crohn’s disease and ulcerative colitis, and brings us closer to finding cures.

For general and in-memory donations, please call 514-342-0666 ext. 201
For French inquiries, please call 514-342-0666 ext. 202


Director, Major Gifts and Corporate Engagement, Québec
Katherine Digby


Development and Community Engagement, Québec, Ontario East
Konstantine Malakos

514-968-2079

Gutsy Learning Sereies logo on background of a public speaker

Navigating Crohn's and colitis in the Workplace: Empowering Tools for Disclosure and Accommodations

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual
 • 
A family gathered around a child looking at a tablet

Ask the Expert: Caregiving and IBD

Are you supporting someone with inflammatory bowel disease (IBD), or living with IBD while providing care to someone else? You're not alone.  Join our free Ask the Expert event designed to ...

 • 
Virtual - Online
 • 
Remember to bookmark this page.

PROVINCE OF QUEBEC’S OFFICE

2110-439 University Avenue
Toronto, ON M5G 1Y8

kdigby@crohnsandcolitis.ca 416-920-5035 or 1-800-387-1479

Search by Postal Code

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

 18 19 20 21 22 23 24 25 26 27